PURPOSE: We recently reported on the identification of the Fas-associated death domain (FADD) as a possible driver of the chromosome 11q13 amplicon and the association between increased FADD expression and disease-specific survival in advanced-stage laryngeal carcinoma. The aim of this study was to examine whether expression of FADD and its Ser194-phosphorylated isoform (pFADD) predicts local control in patients with early-stage glottic carcinoma primarily treated with radiotherapy only. METHODS AND MATERIALS: Immunohistochemical staining for FADD and pFADD was performed on pretreatment biopsy specimens of 92 patients with T1-T2 glottic squamous cell carcinoma primarily treated with radiotherapy between 1996 and 2005. Cox regression analysis was used to correlate expression levels with local control. RESULTS: High levels of pFADD were associated with significantly better local control (hazard ratio, 2.40; 95% confidence interval, 1.04-5.55; p = 0.040). FADD overexpression showed a trend toward better local control (hazard ratio, 3.656; 95% confidence interval, 0.853-15.663; p = 0.081). Multivariate Cox regression analysis showed that high pFADD expression was the best predictor of local control after radiotherapy. CONCLUSIONS: This study showed that expression of phosphorylated FADD is a new prognostic biomarker for better local control after radiotherapy in patients with early-stage glottic carcinomas.
PURPOSE: We recently reported on the identification of the Fas-associated death domain (FADD) as a possible driver of the chromosome 11q13 amplicon and the association between increased FADD expression and disease-specific survival in advanced-stage laryngeal carcinoma. The aim of this study was to examine whether expression of FADD and its Ser194-phosphorylated isoform (pFADD) predicts local control in patients with early-stage glottic carcinoma primarily treated with radiotherapy only. METHODS AND MATERIALS: Immunohistochemical staining for FADD and pFADD was performed on pretreatment biopsy specimens of 92 patients with T1-T2 glottic squamous cell carcinoma primarily treated with radiotherapy between 1996 and 2005. Cox regression analysis was used to correlate expression levels with local control. RESULTS: High levels of pFADD were associated with significantly better local control (hazard ratio, 2.40; 95% confidence interval, 1.04-5.55; p = 0.040). FADD overexpression showed a trend toward better local control (hazard ratio, 3.656; 95% confidence interval, 0.853-15.663; p = 0.081). Multivariate Cox regression analysis showed that high pFADD expression was the best predictor of local control after radiotherapy. CONCLUSIONS: This study showed that expression of phosphorylated FADD is a new prognostic biomarker for better local control after radiotherapy in patients with early-stage glottic carcinomas.
Authors: Brittany M Bowman; Katrina A Sebolt; Benjamin A Hoff; Jennifer L Boes; Danette L Daniels; Kevin A Heist; Craig J Galbán; Rajiv M Patel; Jianke Zhang; David G Beer; Brian D Ross; Alnawaz Rehemtulla; Stefanie Galbán Journal: Sci Signal Date: 2015-01-27 Impact factor: 8.192
Authors: J Cacicedo; F Casquero; O del Hoyo; A Gomez-Iturriaga; L Martinez-Indart; J L Lopez; P Bilbao Journal: Clin Transl Oncol Date: 2013-03-22 Impact factor: 3.405
Authors: Maartje G Noordhuis; Emiel A Kop; Bert van der Vegt; Johannes A Langendijk; Bernard F A M van der Laan; Ed Schuuring; Geertruida H de Bock Journal: Clin Otolaryngol Date: 2020-04-23 Impact factor: 2.597
Authors: José L Marín-Rubio; Laura Vela-Martín; José Fernández-Piqueras; María Villa-Morales Journal: Cancers (Basel) Date: 2019-09-29 Impact factor: 6.639
Authors: Koos Boeve; Mirjam F Mastik; Lorian Slagter-Menkema; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Max J H Witjes; Bert van der Vegt; Ed Schuuring Journal: Head Neck Date: 2021-05-19 Impact factor: 3.147